Liminatus Pharma LIMN
NASDAQ LIMN
$3.90 +0.11 (+2.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Interest & Investment Income (2024 - 2025)

Updated

Liminatus Pharma (LIMN) reported Interest & Investment Income of $76,589 for FY2025, down 37.5% from $122,526 in FY2024.

Analysis

Liminatus Pharma (LIMN) Interest & Investment Income (2024 - 2025) Analysis & Trends

  • According to Business Quant data, Interest & Investment Income came in at $122,526 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Liminatus Pharma 4.37 Mn 4.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 24,383.00
Mar 31, 2025 52,206.00
Dec 31, 2024 43,489.00
Sep 30, 2024 34,481.00
Jun 30, 2024 25,231.00
API Access

Liminatus Pharma Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LIMN&period=max&api_key=YOUR_API_KEY